About Us Services Careers FAQ Contact Us 0
Home Healthcare IT Global Fungal Keratitis Treatment Market Share, Report to 2030
Fungal Keratitis Treatment Market

Fungal Keratitis Treatment Market Size, Share & Trends Analysis Report By Keratitis Type (Noninfectious Keratitis, Infectious Keratitis), By Drug Class (Polyenes, Azoles, Fluorinated Pyrimidines), By Route of Administration (Oral, Injections, Topical Antifungals), By Age Group (0-18 Years, 18-39 Years, 40-64 Years, 65 Years), By Distribution Channel (Hospitals, Drug stores, Others) and By Region(North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2022-2030

Report Code: SRHI1691DR
Last Updated : July 12, 2022
Author : Straits Research
Starting From
USD 2300
Buy Now
File Formats

Table Of Content

  1. Executive Summary
    1. Research Objectives
    2. Limitations & Assumptions
    3. Market Scope & Segmentation
    4. Currency & Pricing Considered
    1. Emerging Regions / Countries
    2. Emerging Companies
    3. Emerging Applications / End Use
    1. Drivers
    2. Market Warning Factors
    3. Latest Macro Economic Indicators
    4. Geopolitical Impact
    5. Technology Factors
    1. Porters Five Forces Analysis
    2. Value Chain Analysis
    1. North America
    2. Europe
    3. APAC
    4. Middle East and Africa
    5. LATAM
  2. ESG Trends
    1. Global Fungal Keratitis Treatment Market Introduction
    2. By Keratitis Type
      1. Introduction
        1. Keratitis Type By Value
      2. Noninfectious Keratitis
        1. By Value
      3. Infectious Keratitis
        1. By Value
        2. Bacterial Keratitis
          1. Bacterial Keratitis By Value
        3. Fungal Keratitis
          1. Fungal Keratitis By Value
        4. Viral Keratitis
          1. Viral Keratitis By Value
        5. Acanthamoeba Keratitis
          1. Acanthamoeba Keratitis By Value
    3. By Drug Class
      1. Introduction
        1. Drug Class By Value
      2. Polyenes
        1. By Value
        2. Natamycin
          1. Natamycin By Value
        3. Amphotericin B
          1. Amphotericin B By Value
      3. Azoles
        1. By Value
        2. Voriconazole
          1. Voriconazole By Value
        3. Ketoconazole
          1. Ketoconazole By Value
        4. Miconazole
          1. Miconazole By Value
        5. Fluconazole
          1. Fluconazole By Value
        6. Itraconazole
          1. Itraconazole By Value
      4. Fluorinated Pyrimidines
        1. By Value
        2. Flucytosine
          1. Flucytosine By Value
        3. Others
          1. Others By Value
    4. By Route of Administration
      1. Introduction
        1. Route of Administration By Value
      2. Oral
        1. By Value
      3. Injections
        1. By Value
      4. Topical Antifungals
        1. By Value
    5. By Age Group
      1. Introduction
        1. Age Group By Value
      2. 0-18 Years
        1. By Value
      3. 18-39 Years
        1. By Value
      4. 40-64 Years
        1. By Value
      5. 65 Years
        1. By Value
    6. By Distribution Channel
      1. Introduction
        1. Distribution Channel By Value
      2. Hospitals
        1. By Value
      3. Drug stores
        1. By Value
      4. Others
        1. By Value
    1. Introduction
    2. By Keratitis Type
      1. Introduction
        1. Keratitis Type By Value
      2. Noninfectious Keratitis
        1. By Value
      3. Infectious Keratitis
        1. By Value
        2. Bacterial Keratitis
          1. Bacterial Keratitis By Value
        3. Fungal Keratitis
          1. Fungal Keratitis By Value
        4. Viral Keratitis
          1. Viral Keratitis By Value
        5. Acanthamoeba Keratitis
          1. Acanthamoeba Keratitis By Value
    3. By Drug Class
      1. Introduction
        1. Drug Class By Value
      2. Polyenes
        1. By Value
        2. Natamycin
          1. Natamycin By Value
        3. Amphotericin B
          1. Amphotericin B By Value
      3. Azoles
        1. By Value
        2. Voriconazole
          1. Voriconazole By Value
        3. Ketoconazole
          1. Ketoconazole By Value
        4. Miconazole
          1. Miconazole By Value
        5. Fluconazole
          1. Fluconazole By Value
        6. Itraconazole
          1. Itraconazole By Value
      4. Fluorinated Pyrimidines
        1. By Value
        2. Flucytosine
          1. Flucytosine By Value
        3. Others
          1. Others By Value
    4. By Route of Administration
      1. Introduction
        1. Route of Administration By Value
      2. Oral
        1. By Value
      3. Injections
        1. By Value
      4. Topical Antifungals
        1. By Value
    5. By Age Group
      1. Introduction
        1. Age Group By Value
      2. 0-18 Years
        1. By Value
      3. 18-39 Years
        1. By Value
      4. 40-64 Years
        1. By Value
      5. 65 Years
        1. By Value
    6. By Distribution Channel
      1. Introduction
        1. Distribution Channel By Value
      2. Hospitals
        1. By Value
      3. Drug stores
        1. By Value
      4. Others
        1. By Value
    7. U.S.
      1. By Keratitis Type
        1. Introduction
          1. Keratitis Type By Value
        2. Noninfectious Keratitis
          1. By Value
        3. Infectious Keratitis
          1. By Value
          2. Bacterial Keratitis
            1. Bacterial Keratitis By Value
          3. Fungal Keratitis
            1. Fungal Keratitis By Value
          4. Viral Keratitis
            1. Viral Keratitis By Value
          5. Acanthamoeba Keratitis
            1. Acanthamoeba Keratitis By Value
      2. By Drug Class
        1. Introduction
          1. Drug Class By Value
        2. Polyenes
          1. By Value
          2. Natamycin
            1. Natamycin By Value
          3. Amphotericin B
            1. Amphotericin B By Value
        3. Azoles
          1. By Value
          2. Voriconazole
            1. Voriconazole By Value
          3. Ketoconazole
            1. Ketoconazole By Value
          4. Miconazole
            1. Miconazole By Value
          5. Fluconazole
            1. Fluconazole By Value
          6. Itraconazole
            1. Itraconazole By Value
        4. Fluorinated Pyrimidines
          1. By Value
          2. Flucytosine
            1. Flucytosine By Value
          3. Others
            1. Others By Value
      3. By Route of Administration
        1. Introduction
          1. Route of Administration By Value
        2. Oral
          1. By Value
        3. Injections
          1. By Value
        4. Topical Antifungals
          1. By Value
      4. By Age Group
        1. Introduction
          1. Age Group By Value
        2. 0-18 Years
          1. By Value
        3. 18-39 Years
          1. By Value
        4. 40-64 Years
          1. By Value
        5. 65 Years
          1. By Value
      5. By Distribution Channel
        1. Introduction
          1. Distribution Channel By Value
        2. Hospitals
          1. By Value
        3. Drug stores
          1. By Value
        4. Others
          1. By Value
    8. Canada
    1. Introduction
    2. By Keratitis Type
      1. Introduction
        1. Keratitis Type By Value
      2. Noninfectious Keratitis
        1. By Value
      3. Infectious Keratitis
        1. By Value
        2. Bacterial Keratitis
          1. Bacterial Keratitis By Value
        3. Fungal Keratitis
          1. Fungal Keratitis By Value
        4. Viral Keratitis
          1. Viral Keratitis By Value
        5. Acanthamoeba Keratitis
          1. Acanthamoeba Keratitis By Value
    3. By Drug Class
      1. Introduction
        1. Drug Class By Value
      2. Polyenes
        1. By Value
        2. Natamycin
          1. Natamycin By Value
        3. Amphotericin B
          1. Amphotericin B By Value
      3. Azoles
        1. By Value
        2. Voriconazole
          1. Voriconazole By Value
        3. Ketoconazole
          1. Ketoconazole By Value
        4. Miconazole
          1. Miconazole By Value
        5. Fluconazole
          1. Fluconazole By Value
        6. Itraconazole
          1. Itraconazole By Value
      4. Fluorinated Pyrimidines
        1. By Value
        2. Flucytosine
          1. Flucytosine By Value
        3. Others
          1. Others By Value
    4. By Route of Administration
      1. Introduction
        1. Route of Administration By Value
      2. Oral
        1. By Value
      3. Injections
        1. By Value
      4. Topical Antifungals
        1. By Value
    5. By Age Group
      1. Introduction
        1. Age Group By Value
      2. 0-18 Years
        1. By Value
      3. 18-39 Years
        1. By Value
      4. 40-64 Years
        1. By Value
      5. 65 Years
        1. By Value
    6. By Distribution Channel
      1. Introduction
        1. Distribution Channel By Value
      2. Hospitals
        1. By Value
      3. Drug stores
        1. By Value
      4. Others
        1. By Value
    7. U.K.
      1. By Keratitis Type
        1. Introduction
          1. Keratitis Type By Value
        2. Noninfectious Keratitis
          1. By Value
        3. Infectious Keratitis
          1. By Value
          2. Bacterial Keratitis
            1. Bacterial Keratitis By Value
          3. Fungal Keratitis
            1. Fungal Keratitis By Value
          4. Viral Keratitis
            1. Viral Keratitis By Value
          5. Acanthamoeba Keratitis
            1. Acanthamoeba Keratitis By Value
      2. By Drug Class
        1. Introduction
          1. Drug Class By Value
        2. Polyenes
          1. By Value
          2. Natamycin
            1. Natamycin By Value
          3. Amphotericin B
            1. Amphotericin B By Value
        3. Azoles
          1. By Value
          2. Voriconazole
            1. Voriconazole By Value
          3. Ketoconazole
            1. Ketoconazole By Value
          4. Miconazole
            1. Miconazole By Value
          5. Fluconazole
            1. Fluconazole By Value
          6. Itraconazole
            1. Itraconazole By Value
        4. Fluorinated Pyrimidines
          1. By Value
          2. Flucytosine
            1. Flucytosine By Value
          3. Others
            1. Others By Value
      3. By Route of Administration
        1. Introduction
          1. Route of Administration By Value
        2. Oral
          1. By Value
        3. Injections
          1. By Value
        4. Topical Antifungals
          1. By Value
      4. By Age Group
        1. Introduction
          1. Age Group By Value
        2. 0-18 Years
          1. By Value
        3. 18-39 Years
          1. By Value
        4. 40-64 Years
          1. By Value
        5. 65 Years
          1. By Value
      5. By Distribution Channel
        1. Introduction
          1. Distribution Channel By Value
        2. Hospitals
          1. By Value
        3. Drug stores
          1. By Value
        4. Others
          1. By Value
    8. Germany
    9. France
    10. Spain
    11. Italy
    12. Russia
    13. Nordic
    14. Benelux
    15. Rest of Europe
    1. Introduction
    2. By Keratitis Type
      1. Introduction
        1. Keratitis Type By Value
      2. Noninfectious Keratitis
        1. By Value
      3. Infectious Keratitis
        1. By Value
        2. Bacterial Keratitis
          1. Bacterial Keratitis By Value
        3. Fungal Keratitis
          1. Fungal Keratitis By Value
        4. Viral Keratitis
          1. Viral Keratitis By Value
        5. Acanthamoeba Keratitis
          1. Acanthamoeba Keratitis By Value
    3. By Drug Class
      1. Introduction
        1. Drug Class By Value
      2. Polyenes
        1. By Value
        2. Natamycin
          1. Natamycin By Value
        3. Amphotericin B
          1. Amphotericin B By Value
      3. Azoles
        1. By Value
        2. Voriconazole
          1. Voriconazole By Value
        3. Ketoconazole
          1. Ketoconazole By Value
        4. Miconazole
          1. Miconazole By Value
        5. Fluconazole
          1. Fluconazole By Value
        6. Itraconazole
          1. Itraconazole By Value
      4. Fluorinated Pyrimidines
        1. By Value
        2. Flucytosine
          1. Flucytosine By Value
        3. Others
          1. Others By Value
    4. By Route of Administration
      1. Introduction
        1. Route of Administration By Value
      2. Oral
        1. By Value
      3. Injections
        1. By Value
      4. Topical Antifungals
        1. By Value
    5. By Age Group
      1. Introduction
        1. Age Group By Value
      2. 0-18 Years
        1. By Value
      3. 18-39 Years
        1. By Value
      4. 40-64 Years
        1. By Value
      5. 65 Years
        1. By Value
    6. By Distribution Channel
      1. Introduction
        1. Distribution Channel By Value
      2. Hospitals
        1. By Value
      3. Drug stores
        1. By Value
      4. Others
        1. By Value
    7. China
      1. By Keratitis Type
        1. Introduction
          1. Keratitis Type By Value
        2. Noninfectious Keratitis
          1. By Value
        3. Infectious Keratitis
          1. By Value
          2. Bacterial Keratitis
            1. Bacterial Keratitis By Value
          3. Fungal Keratitis
            1. Fungal Keratitis By Value
          4. Viral Keratitis
            1. Viral Keratitis By Value
          5. Acanthamoeba Keratitis
            1. Acanthamoeba Keratitis By Value
      2. By Drug Class
        1. Introduction
          1. Drug Class By Value
        2. Polyenes
          1. By Value
          2. Natamycin
            1. Natamycin By Value
          3. Amphotericin B
            1. Amphotericin B By Value
        3. Azoles
          1. By Value
          2. Voriconazole
            1. Voriconazole By Value
          3. Ketoconazole
            1. Ketoconazole By Value
          4. Miconazole
            1. Miconazole By Value
          5. Fluconazole
            1. Fluconazole By Value
          6. Itraconazole
            1. Itraconazole By Value
        4. Fluorinated Pyrimidines
          1. By Value
          2. Flucytosine
            1. Flucytosine By Value
          3. Others
            1. Others By Value
      3. By Route of Administration
        1. Introduction
          1. Route of Administration By Value
        2. Oral
          1. By Value
        3. Injections
          1. By Value
        4. Topical Antifungals
          1. By Value
      4. By Age Group
        1. Introduction
          1. Age Group By Value
        2. 0-18 Years
          1. By Value
        3. 18-39 Years
          1. By Value
        4. 40-64 Years
          1. By Value
        5. 65 Years
          1. By Value
      5. By Distribution Channel
        1. Introduction
          1. Distribution Channel By Value
        2. Hospitals
          1. By Value
        3. Drug stores
          1. By Value
        4. Others
          1. By Value
    8. Korea
    9. Japan
    10. India
    11. Australia
    12. Taiwan
    13. South East Asia
    14. Rest of Asia-Pacific
    1. Introduction
    2. By Keratitis Type
      1. Introduction
        1. Keratitis Type By Value
      2. Noninfectious Keratitis
        1. By Value
      3. Infectious Keratitis
        1. By Value
        2. Bacterial Keratitis
          1. Bacterial Keratitis By Value
        3. Fungal Keratitis
          1. Fungal Keratitis By Value
        4. Viral Keratitis
          1. Viral Keratitis By Value
        5. Acanthamoeba Keratitis
          1. Acanthamoeba Keratitis By Value
    3. By Drug Class
      1. Introduction
        1. Drug Class By Value
      2. Polyenes
        1. By Value
        2. Natamycin
          1. Natamycin By Value
        3. Amphotericin B
          1. Amphotericin B By Value
      3. Azoles
        1. By Value
        2. Voriconazole
          1. Voriconazole By Value
        3. Ketoconazole
          1. Ketoconazole By Value
        4. Miconazole
          1. Miconazole By Value
        5. Fluconazole
          1. Fluconazole By Value
        6. Itraconazole
          1. Itraconazole By Value
      4. Fluorinated Pyrimidines
        1. By Value
        2. Flucytosine
          1. Flucytosine By Value
        3. Others
          1. Others By Value
    4. By Route of Administration
      1. Introduction
        1. Route of Administration By Value
      2. Oral
        1. By Value
      3. Injections
        1. By Value
      4. Topical Antifungals
        1. By Value
    5. By Age Group
      1. Introduction
        1. Age Group By Value
      2. 0-18 Years
        1. By Value
      3. 18-39 Years
        1. By Value
      4. 40-64 Years
        1. By Value
      5. 65 Years
        1. By Value
    6. By Distribution Channel
      1. Introduction
        1. Distribution Channel By Value
      2. Hospitals
        1. By Value
      3. Drug stores
        1. By Value
      4. Others
        1. By Value
    7. UAE
      1. By Keratitis Type
        1. Introduction
          1. Keratitis Type By Value
        2. Noninfectious Keratitis
          1. By Value
        3. Infectious Keratitis
          1. By Value
          2. Bacterial Keratitis
            1. Bacterial Keratitis By Value
          3. Fungal Keratitis
            1. Fungal Keratitis By Value
          4. Viral Keratitis
            1. Viral Keratitis By Value
          5. Acanthamoeba Keratitis
            1. Acanthamoeba Keratitis By Value
      2. By Drug Class
        1. Introduction
          1. Drug Class By Value
        2. Polyenes
          1. By Value
          2. Natamycin
            1. Natamycin By Value
          3. Amphotericin B
            1. Amphotericin B By Value
        3. Azoles
          1. By Value
          2. Voriconazole
            1. Voriconazole By Value
          3. Ketoconazole
            1. Ketoconazole By Value
          4. Miconazole
            1. Miconazole By Value
          5. Fluconazole
            1. Fluconazole By Value
          6. Itraconazole
            1. Itraconazole By Value
        4. Fluorinated Pyrimidines
          1. By Value
          2. Flucytosine
            1. Flucytosine By Value
          3. Others
            1. Others By Value
      3. By Route of Administration
        1. Introduction
          1. Route of Administration By Value
        2. Oral
          1. By Value
        3. Injections
          1. By Value
        4. Topical Antifungals
          1. By Value
      4. By Age Group
        1. Introduction
          1. Age Group By Value
        2. 0-18 Years
          1. By Value
        3. 18-39 Years
          1. By Value
        4. 40-64 Years
          1. By Value
        5. 65 Years
          1. By Value
      5. By Distribution Channel
        1. Introduction
          1. Distribution Channel By Value
        2. Hospitals
          1. By Value
        3. Drug stores
          1. By Value
        4. Others
          1. By Value
    8. Turkey
    9. Saudi Arabia
    10. South Africa
    11. Egypt
    12. Nigeria
    13. Rest of MEA
    1. Introduction
    2. By Keratitis Type
      1. Introduction
        1. Keratitis Type By Value
      2. Noninfectious Keratitis
        1. By Value
      3. Infectious Keratitis
        1. By Value
        2. Bacterial Keratitis
          1. Bacterial Keratitis By Value
        3. Fungal Keratitis
          1. Fungal Keratitis By Value
        4. Viral Keratitis
          1. Viral Keratitis By Value
        5. Acanthamoeba Keratitis
          1. Acanthamoeba Keratitis By Value
    3. By Drug Class
      1. Introduction
        1. Drug Class By Value
      2. Polyenes
        1. By Value
        2. Natamycin
          1. Natamycin By Value
        3. Amphotericin B
          1. Amphotericin B By Value
      3. Azoles
        1. By Value
        2. Voriconazole
          1. Voriconazole By Value
        3. Ketoconazole
          1. Ketoconazole By Value
        4. Miconazole
          1. Miconazole By Value
        5. Fluconazole
          1. Fluconazole By Value
        6. Itraconazole
          1. Itraconazole By Value
      4. Fluorinated Pyrimidines
        1. By Value
        2. Flucytosine
          1. Flucytosine By Value
        3. Others
          1. Others By Value
    4. By Route of Administration
      1. Introduction
        1. Route of Administration By Value
      2. Oral
        1. By Value
      3. Injections
        1. By Value
      4. Topical Antifungals
        1. By Value
    5. By Age Group
      1. Introduction
        1. Age Group By Value
      2. 0-18 Years
        1. By Value
      3. 18-39 Years
        1. By Value
      4. 40-64 Years
        1. By Value
      5. 65 Years
        1. By Value
    6. By Distribution Channel
      1. Introduction
        1. Distribution Channel By Value
      2. Hospitals
        1. By Value
      3. Drug stores
        1. By Value
      4. Others
        1. By Value
    7. Brazil
      1. By Keratitis Type
        1. Introduction
          1. Keratitis Type By Value
        2. Noninfectious Keratitis
          1. By Value
        3. Infectious Keratitis
          1. By Value
          2. Bacterial Keratitis
            1. Bacterial Keratitis By Value
          3. Fungal Keratitis
            1. Fungal Keratitis By Value
          4. Viral Keratitis
            1. Viral Keratitis By Value
          5. Acanthamoeba Keratitis
            1. Acanthamoeba Keratitis By Value
      2. By Drug Class
        1. Introduction
          1. Drug Class By Value
        2. Polyenes
          1. By Value
          2. Natamycin
            1. Natamycin By Value
          3. Amphotericin B
            1. Amphotericin B By Value
        3. Azoles
          1. By Value
          2. Voriconazole
            1. Voriconazole By Value
          3. Ketoconazole
            1. Ketoconazole By Value
          4. Miconazole
            1. Miconazole By Value
          5. Fluconazole
            1. Fluconazole By Value
          6. Itraconazole
            1. Itraconazole By Value
        4. Fluorinated Pyrimidines
          1. By Value
          2. Flucytosine
            1. Flucytosine By Value
          3. Others
            1. Others By Value
      3. By Route of Administration
        1. Introduction
          1. Route of Administration By Value
        2. Oral
          1. By Value
        3. Injections
          1. By Value
        4. Topical Antifungals
          1. By Value
      4. By Age Group
        1. Introduction
          1. Age Group By Value
        2. 0-18 Years
          1. By Value
        3. 18-39 Years
          1. By Value
        4. 40-64 Years
          1. By Value
        5. 65 Years
          1. By Value
      5. By Distribution Channel
        1. Introduction
          1. Distribution Channel By Value
        2. Hospitals
          1. By Value
        3. Drug stores
          1. By Value
        4. Others
          1. By Value
    8. Mexico
    9. Argentina
    10. Chile
    11. Colombia
    12. Rest of LATAM
    1. Fungal Keratitis Treatment Market Share By Players
    2. M&A Agreements & Collaboration Analysis
    1. Bausch Health Companies Inc.
      1. Overview
      2. Business Information
      3. Revenue
      4. ASP
      5. SWOT Analysis
      6. Recent Developments
    2. Glenmark Pharmaceuticals
    3. Merck & Co. Inc.
    4. Aurolab
    5. Eyevance Pharmaceuticals LLC
    6. Pfizer Inc
    7. Leadiant Biosciences, Inc.
    8. Novartis
    9. CHL Health Limited
    10. Wellona Pharma
    11. LEXICARE PHARMA PVT. LTD
    1. Research Data
      1. Secondary Data
        1. Major secondary sources
        2. Key data from secondary sources
      2. Primary Data
        1. Key data from primary sources
        2. Breakdown of primaries
      3. Secondary And Primary Research
        1. Key industry insights
    2. Market Size Estimation
      1. Bottom-Up Approach
      2. Top-Down Approach
      3. Market Projection
    3. Research Assumptions
      1. Assumptions
    4. Limitations
    5. Risk Assessment
    1. Discussion Guide
    2. Customization Options
    3. Related Reports
  3. Disclaimer

Related Reports

Global Report
Global Uveitis Treatment Market Size The global uveitis treatment market size was valued at USD 2.28 billion in 2024 and is expected to grow from USD 2.49 billion in 2025 to reach USD 4.88 billion by 2033, growing at a CAGR of 8.8% du
Buy Now

Purchase Benefits

  • Eligible for a free updated report next year
  • Completely customizable scope
  • 30% discount on your next purchase
  • Dedicated account manager
  • Query resolution within 24 hours
  • Permission to print the report

We are featured on :

www.straitsresearch.com
© Copyright 2025. All rights Reserved.